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Rapprochement of research and practiceFor various reasons, it is important that clinical research
and practice match as much as possible [1]. First, clinical re-
search questions should address problems that are or will be
encountered in clinical practice. Second, to produce both
convincing and useful results, and as a favorable start of im-
plementation processes, research designs and methods
should integrate real practice data, experiences, and chal-
lenges as much as possible. And third, given the fast devel-
opment of new clinical fields to be explored and new
interventions to be tested with limited research resources
and patient recruitment opportunities, designing new studies
for every piece of the knowledge mosaic separately is not a
sustainable strategy for the future: research designs should
as much as possible converge with practice, serving both in-
ternal and external validity. An additional advantage would
be that care quality could more directly benefit from better
standardization of procedures and observations.
As to the first two of these issues e clinical relevance of
research questions and the match between research meth-
ods and clinical practice e the Variance and Dissent series
on ‘the comprehensive diagnostic study,’ presents important
experiences, ideas, and insights. The series starts with an
original article by Donner-Banzhof et al., who propose
the comprehensive diagnostic study to deal better with clin-
ical presentations where a large number of diagnostic tests
or even diagnostic strategies should be evaluated in relation
to several diseases or disease categories, as is often the case
in primary care research. This is followed by a discussion
between these authors and Van den Bruel and Perera.
The latter put forward that, while the importance of
symptom-based presentations and dealing with several dis-
ease outcomes has earlier been recognized, with many stud-
ies already having been published, a number of difficulties
have not yet been solved, such as: too few data in very spe-
cific subgroups, dealing with rare but severe diseases, defin-
ing appropriate reference standards, and problems such as
model overfitting and lack of appropriate precision esti-
mates. Donner-Banzhof et al. further discuss these issues,
and emphasize that we should move away from the need
of ‘‘one study being conducted for each disease of rele-
vance in a defined clinical situation.’’ Indeed, more com-
prehensive studies may help to develop research strategies
beyond conducting separate studies for every new mosaic
piece of knowledge. Together with both teams of discus-
sants, we would welcome more work and progress on this
topic.0895-4356/$ - see front matter  2014 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.jclinepi.2013.11.010An important practice-relevant addition to the already
quite long and lively international publication record of
clinical epidemiological research on diagnostic tests is the
work being done on using tests to study disease develop-
ment over time and to monitor patients with chronic dis-
eases. In this context, Bell et al. describe how evidence
from trials and cohort studies may be used to guide choice
of tests for monitoring purposes. They propose four specific
criteria that can support evidence-based decision making on
which tests to use, and illustrate this with clinical examples.
Not only diagnostic but also treatment choices are often
more complex than simple yes-no decisions. It is therefore
interesting to see to how the reporting of mixed treatment
comparisons (MTCs) in published systematic reviews is de-
veloping over time. In a narrative review of systematic re-
views, Lee shows that such publications have increased
rapidly in recent years. However, as such reports are diffi-
cult to identify with current search methods, the authors
make a plea for indexing MTCs in databases and for con-
sensus on standards for conducting and reporting them.
Sustainability, not only of mosaic-pieceespecific clinical
research, but also of health care services, is a matter of grow-
ing concern internationally. In this connection, the work by
Haines c.s. on developing a feasible research design to eval-
uate disinvestment in health technologies of uncertain (or
even absent) effectiveness or cost-effectiveness is very rele-
vant. They discuss related methodological options, with
special attention for potentials and limitations of the
stepped-wedged, roll-in cluster randomized trial design.
For efficient epidemiological and health care research,
cause-of-death registers and the possibility to link these
to other data sources are essential, and continuously evalu-
ating and promoting the validity of such approaches is im-
portant. Klijs et al. investigated to what extent underlying
and multiple causes of death data represent end-of-life hos-
pital morbidity data in individuals and at population level.
There was poor agreement at individual level but reason-
able agreement at population level. The implications of
these findings are discussed.
For scientific, practical, and budgetary reasons, efficient
recruitment of participants is paramount, and knowledge
on factors that influence this process is very helpful. Based
on data from a large randomized trial of low back pain in
primary care, Williams and co-authors found that a higher
socio-economic status of the area, a prompt follow-up after
the initial study training of GPs, and a higher number of
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rate. While the ability to predict recruitment based on GP
characteristics seems limited, these insights can be helpful
to improve recruitment procedures. The latter was also the
aim of the study of Drummond et al., who evaluated two
monetary incentives (‘‘bird in the hand cash’’ and ‘‘prize
draws’’) in increasing the response rates to postal question-
naires from primary care physicians. From a 3-arm random-
ized trial, also including a no-incentive group, it was
concluded that both incentives worked, but the (modest)
cash incentive was most effective and cost-effective.
Van Kempen and co-workers focused on improving the
identification of frail older people in primary care, and
tested a 2-step tool they developed for this purpose among
patients 70 years of age or older. They concluded that their
instrument, the EASY-Care Two-step Older Persons
Screening, correlated well with physical and social meas-
ures, and that the tool can identify patients with a wide
spectrum of interacting problems.
Valid and efficient sampling is a classic topic in clinical
epidemiology. But, as van Rein and co-authors emphasize,
with regard to (in)appropriate subject selection in case-
control studies, there has been much less attention paid to
case than to control sampling. Using a case-control study
on the effect of statins on major bleedings during treatment
with vitamin K antagonists as an example, they describe
how to detect survivor bias and how to deal with it in order
to check for over-optimistic results.
In the evaluation of screening for colorectal cancer, a
common approach is to compare observed numbers of col-
orectal cancer (CRC) deaths in screening participants with
expected numbers derived from general population data.
Using the cancer registry data, Brenner et al. illustrate that
this approach can lead to substantial overestimation of ex-
pected CRC deaths in screening cohorts. They make recom-
mendations for deriving valid screening effect estimates.
In the study of life course epidemiology, the analysis of
longitudinal observational data is often necessary to infer
on the plausibility and consistency of causal models. La
Bastide-van Gemert et al. exemplify a statistical tool using
directed acyclic graphs (DAGs) for exploring causal infer-
ence, based on data from the Prevention of Renal and Vas-
cular Endstage Disease study. They recommend that search
algorithms and causal diagrams should be used in addition
to more traditional approaches. Another application of di-
rected acyclic graphs is presented by R€ohrig and her team,
to examine the association between electrocardiographic
findings and disability status in older adults. They demon-
strated that associations found in unadjusted analysis and
in age- and sex-adjusted logistic models were no longer sig-
nificant when adjusting for other possible confounders
identified by the DAG method. The authors stress the im-
portance of adequately identifying confounding.
Developing and testing subjective well-being measures
for adults have already received much attention from the
clinical research community, but for children this has notbeen the case. Therefore, Ravens-Sieberer and her group
worked to conceptualize children’s subjective well-being
(SWB) and to produce appropriate item pools to be used
in computerized adaptive testings (CATs), based on inter-
views with experts, children, and parents. They demon-
strate that children and adolescents were able to
comprehend and respond to questions about happiness,
meaningful life, optimism, and goal orientation, and formu-
late further steps for research.
In economic evaluations, the quality weight to assess the
number of QALYs can be gained from appropriate
preference-based measures. Wong c.s. compared the inter-
nal and external responsiveness of 3 preference-based SF-
6D indices in patients with CRC. Based on their results,
they conclude that the use of a preference-based index map-
ped from a condition-specific measure improved respon-
siveness in patients with CRC.
Many years after the introduction of the ‘numbers needed
to treat’ method, there is still discussion on how it should be
best applied and interpreted. Girerd and colleagues react to a
previous article on this subject, highlighting differences be-
tween a risk difference (RD) and an incidence rate difference
(IRD) approach [2], and Bender and colleagues respond. An
informative correspondence is also conducted between
McGregor and Guyatt et al., on the limitations and advan-
tages of weak recommendations in the context of the
GRADE guidelines [3,4] and on the evidence base to support
GRADE formatting recommendations.
The submissions to the Journal of Clinical Epidemiol-
ogy have substantially increased in recent years, a develop-
ment also observed by many other journals. Submitting a
scientific paper is indeed a very frequent intervention in
the career of researchers. We, therefore, recommend the
new 1-pager by Kotz and Cals on effective writing and pub-







[1] Knottnerus JA, Dinant GJ. Medicine based evidence, a prerequisite for
evidence based medicine. BMJ 1997;315:1109e10.
[2] Bender R, Kromp M, Kiefer C, Sturtz S. Absolute risks rather than in-
cidence rates should be used to estimate the number needed to treat
from time-to-event data. J Clin Epidemiol 2013;66:1038e44.
[3] Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y,
et al. GRADE guidelines: 14. Going from evidence to recommenda-
tions: the significance and presentation of recommendations. J Clin
Epidemiol 2013;66:719e25.
[4] Andrews JC, Sch€unemann HJ, Oxman AD, Pottie K, Meerpohl JJ,
Coello PA, et al. GRADE guidelines: 15. Going from evidence to
recommendation-determinants of a recommendation’s direction and
strength. J Clin Epidemiol 2013;66:726e35.
